Triple-Drug cocktail targets Hard-to-Treat mesothelioma
Disease control
Ongoing
This phase 2 trial tests a combination of three types of drugs—an immunotherapy (pembrolizumab), a targeted therapy (lenvatinib), and chemotherapy (pemetrexed plus cisplatin or carboplatin)—as a first treatment for people with advanced malignant pleural mesothelioma that cannot b…
Phase: PHASE2 • Sponsor: Hyogo Medical University • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC